TYRA — Tyra Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $1.43bn
- $1.15bn
- 59
- 20
- 97
- 61
Annual cashflow statement for Tyra Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.34 | -26.3 | -55.3 | -69.1 | -86.5 |
| Depreciation | |||||
| Non-Cash Items | 0.454 | 2.89 | 10.6 | 12.3 | 16.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.07 | -0.481 | -5.85 | 6.36 | -0.729 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.76 | -23.7 | -50.3 | -50.1 | -69.8 |
| Capital Expenditures | -0.312 | -0.661 | -0.559 | -0.77 | -0.664 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.016 | 0 | -144 | -97.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.312 | -0.645 | -0.559 | -145 | -98.4 |
| Financing Cash Flow Items | — | -0.025 | — | — | -0.42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.4 | 311 | 0.632 | 1.54 | 202 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.4 | 287 | -50.2 | -193 | 34 |